CoChat

Predictors of Time-in-Range (70–180 mg/dL) Achieved Using a Closed-Loop Control System

Open access
Schoelwer, Melissa J., Kanapka, Lauren G., Wadwa, R. Paul, Breton, Marc D., Ruedy, Katrina J., Ekhlaspour, Laya, Forlenza, Gregory P., Cobry, Erin C., Messer, Laurel H., Cengiz, Eda, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J., Weinzimer, Stuart A., Buckingham, Bruce A., Lal, Rayhan A., Oliveri, Mary Clancy, Kollman, Craig C., Dokken, Betsy B., Cherñavvsky, Daniel R., Beck, Roy W., DeBoer, Mark D., for the iDCL Trial Research Group, Gonder-Frederick, Linda, Robic, Jessica, Voelmle, Mary, Conschafter, Katie, Morris, Kimberly, Barnett, Charlotte, Carr, Kelly, Hellmann, Jacob, Kime, Matthew, Todd Alonso, G., Slover, Robert, Berget, Cari, Towers, Lindsey, Lange, Samantha, Buckingham, Bruce, Maahs, David, Lal, Rayhan, Ekhlaspour, Laya, Norlander, Lisa, Hood, Korey, Town, Marissa, Weir, Christine, Smith, Kerren, Hsu, Liana, Shinksy, Deanna, Viana, Julia, Cengiz, Eda, Weinzimer, Stuart, Weyman, Kate, Carria, Lori, Zgorski, Melinda, Ruedy, Katrina, Beck, Roy, Borgman, Sarah, Rusnak, Jessica, Kanapka, Lauren, Kollman, Craig, Murphy, Carlos, Arreza-Rubin, Guillermo, Green, Neal, Kovatchev, Boris, Brown, Sue, Anderson, Stacey, Breton, Marc, Laffel, Lori, Pinsker, Jordan, Levy, Carol, Kudva, Yogish C., Wadwa, R. Paul, Buckingham, Bruce, Doyle III, Francis, Renard, Eric, Cobelli, Claudio, Reznik, Yves, Arreza-Rubin, Guillermo, Lum, John, Beck, Roy, Ruedy, Katrina, Janicek, Robert, Gabrielson, Deanna · 2021 · Diabetes Technology & Therapeutics
Cited by 63

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased time-in-range (TIR) 70–180 mg/dL. However, clinical predictors of TIR in users of CLC systems are needed. Materials and Methods: We analyzed data from 100 children aged 6–13 years with T1D using the Tandem Control-IQ CLC system during a randomized trial or subsequent extension phase. Continuous glucose monitor data were collected at baseline and during 12–16 weeks of CLC use. Participants were stratified into quartiles of TIR on CLC to compare clinical characteristics. Results: TIR for those in the first, second, third, and fourth quartiles was 54%, 65%, 71%, and 78%, respectively. Lower baseline TIR was associated with lower TIR on CLC ( r = 0.69, P < 0.001). However, lower baseline TIR was also associated with greater improvement in TIR on CLC ( r = −0.81, P < 0.001). During CLC, participants in the highest versus lowest TIR-quartile administered more user-initiated boluses daily (8.5 ± 2.8 vs. 5.8 ± 2.6, P < 0.001) and received fewer automated boluses (3.5 ± 1.0 vs. 6.0 ± 1.6, P < 0.001). Participants in the lowest (vs. the highest) TIR-quartile received more insulin per body weight (1.13 ± 0.27 vs. 0.87 ± 0.20 U/kg/d, P = 0.008). However, in a multivariate model adjusting for baseline TIR, user-initiated boluses and insulin-per-body-weight were no longer significant. Conclusions: Higher baseline TIR is the strongest predictor of TIR on CLC in children with T1D. However, lower baseline TIR is associated with the greatest improvement in TIR. As with open-loop systems, user engagement is important for optimal glycemic control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2020.0646

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 63

Metadata

Authors
Schoelwer, M. J., Kanapka, L. G., Wadwa, R. P., Breton, M. D., Ruedy, K. J., Ekhlaspour, L., Forlenza, G. P., Cobry, E. C., Messer, L. H., Cengiz, E., Jost, E., Carria, L., Emory, E., Hsu, L. J., Weinzimer, S. A., Buckingham, B. A., Lal, R. A., Oliveri, M. C., Kollman, C. C., Dokken, B. B., Cherñavvsky, D. R., Beck, R. W., DeBoer, M. D., for the iDCL Trial Research Group, Gonder-Frederick, L., Robic, J., Voelmle, M., Conschafter, K., Morris, K., Barnett, C., Carr, K., Hellmann, J., Kime, M., Todd Alonso, G., Slover, R., Berget, C., Towers, L., Lange, S., Buckingham, B., Maahs, D., Lal, R., Ekhlaspour, L., Norlander, L., Hood, K., Town, M., Weir, C., Smith, K., Hsu, L., Shinksy, D., Viana, J., Cengiz, E., Weinzimer, S., Weyman, K., Carria, L., Zgorski, M., Ruedy, K., Beck, R., Borgman, S., Rusnak, J., Kanapka, L., Kollman, C., Murphy, C., Arreza-Rubin, G., Green, N., Kovatchev, B., Brown, S., Anderson, S., Breton, M., Laffel, L., Pinsker, J., Levy, C., Kudva, Y. C., Wadwa, R. P., Buckingham, B., Doyle III, F., Renard, E., Cobelli, C., Reznik, Y., Arreza-Rubin, G., Lum, J., Beck, R., Ruedy, K., Janicek, R., & Gabrielson, D.
Venue
Diabetes Technology & Therapeutics
Published
2021-07-01
Volume
23
Issue
7
Pages
475-481
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W3135247164
Cited by
63
References
8
FWCI
7.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.